MDGL Historical Earnings image   This MDGL historical earnings page last updated 4/24/2024
MDGL Historical Revenue
PeriodHistorical Earnings DateGAAP
Q4 20232/28/2024NA
Q3 202311/6/2023NA
Q2 20238/8/2023NA
Q1 20235/9/2023NA
Q4 20222/23/2023NA
Q3 202211/3/2022NA
Q2 20228/4/2022NA
Q1 20225/9/2022NA
Q4 20212/24/2022NA
Q3 202111/4/2021NA
Q2 20218/5/2021NA
Q1 20215/6/2021NA
Q4 20202/25/2021NA
Q3 202011/5/2020NA
Q2 20208/6/2020NA
Q1 20205/7/2020NA
Q4 20192/26/2020NA
Q3 201911/6/2019NA
Q2 20198/7/2019NA
Q1 20195/8/2019NA
MDGL Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q4 20232/28/2024-5.680
Q3 202311/6/2023-5.340
Q2 20238/8/2023-4.690
Q1 20235/9/2023-4.230
Q4 20222/23/2023-4.980
Q3 202211/3/2022-4.750
Q2 20228/4/2022-4.140
Q1 20225/9/2022-3.360
Q4 20212/24/2022-3.780
Q3 202111/4/2021-3.790
Q2 20218/5/2021-3.720
Q1 20215/6/2021-3.320
Q4 20202/25/2021-3.820
Q3 202011/5/2020-3.750
Q2 20208/6/2020-3.180
Q1 20205/7/2020-2.340
Q4 20192/26/2020-1.800
Q3 201911/6/2019-1.390
Q2 20198/7/2019-1.280
Q1 20195/8/2019-0.980
Quotes delayed 20 minutes

Email EnvelopeFree MDGL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Madrigal Pharmaceuticals (MDGL) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

MDT Historical Earnings
MDXG Historical Earnings
ME Historical Earnings
MEDP Historical Earnings
MEIP Historical Earnings
MGLN Historical Earnings
MGNX Historical Earnings
MGTA Historical Earnings
MIRM Historical Earnings
MIRO Historical Earnings
What was the record high MDGL historical earnings result?
In terms of earnings or revenue, what is the best MDGL historical earnings result that Madrigal Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest MDGL historical earnings result was set in Q1 2019, when Madrigal Pharmaceuticals posted results of -0.980/share. The most successful revenue quarter within our data set was Q4 2023 when Madrigal Pharmaceuticals reported revenue of NA.

What was the lowest Madrigal Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest MDGL has reported, and when?

✔️Accepted answer: Within our data set, the lowest MDGL historical earnings result was set in Q4 2023, when Madrigal Pharmaceuticals posted results of -5.680/share. The smallest revenue quarter within our data set was Q4 2023 when Madrigal Pharmaceuticals reported revenue of NA.

On this page we presented the MDGL historical earnings date information for Madrigal Pharmaceuticals. Reviewing that MDGL Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2019, when MDGL posted gaap of -0.980/share. Meanwhile the lowest MDGL historical earnings result was in Q4 2023, when MDGL posted gaap of -5.680/share. Moving to Madrigal Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2023 when MDGL reported NA in revenue, while the smallest revenue quarter was Q4 2023 when MDGL reported NA in revenue.

For self directed investors doing their due diligence on MDGL or any other given stock, their research can benefit from looking into all of the Madrigal Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Madrigal Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for MDGL. Thanks for visiting, and the next time you need to research MDGL historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Top 10 Hedge Funds Holding Prudential Financial, INDB Dividend Growth Rate, ARCW Options Chain.

 

MDGL Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.